Literature DB >> 12562664

Amelioration of docetaxel/cisplatin induced polyneuropathy by alpha-lipoic acid.

C Gedlicka, G V Kornek, K Schmid, W Scheithauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12562664     DOI： 10.1093/annonc/mdg051

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  16 in total

1.  Alpha-lipoic acid and frataxin: a new indication for an old antioxidant?

Authors:  James W Russell
Journal:  Exp Neurol       Date:  2009-04-15       Impact factor: 5.330

Review 2.  Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies.

Authors:  Gerardo Gutiérrez-Gutiérrez; María Sereno; Ambrosio Miralles; Enrique Casado-Sáenz; Eduardo Gutiérrez-Rivas
Journal:  Clin Transl Oncol       Date:  2010-02       Impact factor: 3.405

Review 3.  Therapeutic strategies for cancer treatment related peripheral neuropathies.

Authors:  Deirdre R Pachman; James C Watson; Charles L Loprinzi
Journal:  Curr Treat Options Oncol       Date:  2014-12

4.  Protective Effect of Alpha Lipoic Acid on Rat Sciatic Nerve Ischemia Reperfusion Damage.

Authors:  Ozan Turamanlar; Oğuz Aslan Özen; Ahmet Songur; Murat Yağmurca; Sezer Akçer; Hakan Mollaoğlu; Cevat Aktaş
Journal:  Balkan Med J       Date:  2015-04-01       Impact factor: 2.021

Review 5.  Interventions for preventing neuropathy caused by cisplatin and related compounds.

Authors:  James W Albers; Vinay Chaudhry; Guido Cavaletti; Ross C Donehower
Journal:  Cochrane Database Syst Rev       Date:  2011-02-16

6.  Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study.

Authors:  Isacco Desideri; Giulio Francolini; Carlotta Becherini; Francesca Terziani; Camilla Delli Paoli; Emanuela Olmetto; Mauro Loi; Marco Perna; Icro Meattini; Vieri Scotti; Daniela Greto; Pierluigi Bonomo; Susanna Sulprizio; Lorenzo Livi
Journal:  Med Oncol       Date:  2017-02-15       Impact factor: 3.064

7.  A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors.

Authors:  Jennifer S Gewandter; Supriya G Mohile; Charles E Heckler; Julie L Ryan; Jeffrey J Kirshner; Patrick J Flynn; Judith O Hopkins; Gary R Morrow
Journal:  Support Care Cancer       Date:  2014-02-16       Impact factor: 3.603

Review 8.  Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN).

Authors:  Yaqin Han; Maree T Smith
Journal:  Front Pharmacol       Date:  2013-12-18       Impact factor: 5.810

Review 9.  Management options for established chemotherapy-induced peripheral neuropathy.

Authors:  Deirdre R Pachman; James C Watson; Maryam B Lustberg; Nina D Wagner-Johnston; Alexandre Chan; Larry Broadfield; Yin Ting Cheung; Christopher Steer; Dawn J Storey; Kavita D Chandwani; Judith Paice; Pascal Jean-Pierre; Jeong Oh; Jayesh Kamath; Marie Fallon; Herwig Strik; Susanne Koeppen; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2014-05-31       Impact factor: 3.359

Review 10.  Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy.

Authors:  Aparna Areti; Veera Ganesh Yerra; Vgm Naidu; Ashutosh Kumar
Journal:  Redox Biol       Date:  2014-01-18       Impact factor: 11.799
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.